Nadofaragene firadenovec
Conventional medicine
Nadofaragene firadenovec, sold under the brand name Adstiladrin, is a gene therapy for the treatment of bladder cancer. It is a non-replicating adenoviral vector-based gene therapy.
Conventional medicine
Nadofaragene firadenovec, sold under the brand name Adstiladrin, is a gene therapy for the treatment of bladder cancer. It is a non-replicating adenoviral vector-based gene therapy.